| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Pharmacokinetics and Pharmacodynamics | 4 | Dose respone curve ,Drug potency,Non competitive inhibition, Digoxin pharmacokinetics , Dosing rate of drug formula | High | 0.5 |
| Enzyme inducers and inhibitors | 2 | Erythromycin inhibiting effect of Theophylline | Moderate | 0.25 |
| Drug prescription | 1 | Alprazolam | Low | 0.25 |
| Drug dosing | 1 | Loading dose dependent on volume of distribution | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Anti TB | 5 | Isoniazid (asked twice) ,Inclusion criteria for Bedaquiline ,Rifampicin-,MOA induces OCP metabolism, Pyridoxine supplementation with Isoniazid | High | 1 |
| Antimalarials | 3 | Chloroquine-side effect-gets deposited in cornea (asked twice) | High | 0.5 |
| Antifungal | 3 | Clotrimazole- treatment of oral thrush, Amphotercin B-treatment of mucor, Azoles- Voriconazole not useful in mucormycosis | High | 0.5 |
| Antimicrobials | 3 | Floroquinolones-Pefloxacin contraindicated in liver disease, Mechanism of action, Mechanism of resistnace in Bera-lactams,Clarithromycin can cause digoxin toxicity | High | 1 |
| Antiparasitic | 1 | Metronidazole- Disulfiram reaction with alcohol | Low | 0.5 |
| AntiHIV | 1 | Drug interaction with Rifampicin | Low | 0.5 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Antihypertensives | 7 | Bisoprolol (imoproves cardiac mortality ), Clonidine - rebound hypertension (asked twice),Omapratilat-Mechanism of action,ARB-Losartan - Drug induced angioedema, Drugs contraindicated in pregnancy | High | 1 |
| Antiarrhythmic | 6 | Amiodarone-adverse effects (asked thrice),Digoxin toxicity - Digifab(asked twice),Adenosine | High | 1 |
| Antianginal | 2 | Ranolazine-MOA | Moderate | 0.25 |
| Drugs for Dyslipidemia | 2 | Nicotinamide adverse effects,Evolocumab-MOA | Moderate | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Antiparkinsons | 3 | Trihexiphenidyl/Benzhexol- Drug induced dyskinesia (asked twice) , Selegiline | High | 0.75 |
| Antipsychotic and Antidepressant | 3 | Lithium-toxicity, SNRI - Reboxatine | High | 0.75 |
| Benzodiazepine | 1 | Alprazolam prescription in the night | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Antimuscarinic | 7 | Atropine-OP poisoning treatment (asked thrice ),Dhatura poisoning , Tolterodine, Botulinum toxin | High | 1.5 |
| Anti adrenergic | 1 | Tamsulosin | Low | 0.25 |
| Epinephrine | 1 | Shifts potassium into cells | Low | 0.25 |
| Methylphenidate | 1 | used in treatment of ADHD | Low | 0.25 |
| Reversal of Anaesthesia/ Muscle relaxant | 1 | Neostigmine for revrsal of Vecuronium in renal failure | Low | 0.25 |
| Muscarinic | 1 | Bethanechol for post operative urinary retention | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| GH analogue , Inhibition | 3 | Pegvisomant-indication, Tesamorelin-HIV associated Lipodystrophy, Octreotide-GH producing tumor-Acromegaly treatment | High | 0.75 |
| OHA | 2 | Metformin (asked twice) | Moderate | 1 |
| Osteoporosis | 2 | Bisphosphanates | Moderate | 0.75 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| NSAIDs | 5 | Aspirin-,Mechanism of action ,Samters triad, Toxicity(asked thrice ) ,Indomethacin-premature closure of PDA ( asked twice ) | High | 1 |
| Opioids and withdrawal | 2 | Buprenorphine- opiod withdrawal , Morphine-aggravates biliary colic | Moderate | 0.5 |
| Prostaglandins | 2 | Carboprost-CI in treatment of PPH with Asthma , Latanoprost-Antiglaucoma | Moderate | 0.5 |
| Antispasmodic | 1 | Dicyclomine | Low | 0.25 |
| Analgesic in CKD | 1 | Acetaminophen can be used | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Anticoagulants and Fibrinolytics | 5 | warfarin-Purple toe syndrome (asked twice ) , Vitamin K-deficiency causing bleeding ( asked twice ), Tissue plasminogen activator- MOA,LMWH - pregnant with DVT | High | 1.5 |
| Methotrexate | 2 | Reduced synthesis of TMP, competitive inhibitor of DHFR | Moderate | 0.5 |
| Bortezomib | 1 | Increase risk of zoster | Low | 0.25 |
| Operlvekin | 1 | Treatment of chemotherapy induced thrombocytopenia | Low | 0.25 |
| Hemostatics | 1 | Aminocaproic acid- Mechanism of action | Low | 0.25 |
| Antimetabolites | 1 | 6-Mercaptopurine | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Antiemetics | 5 | Prokinetic agents , Metoclopramide-side effects , Promethazine- treatment of motion sickness ( asked twice ),Aprepitant-MOA | High | 0.5 |
| Antidiarrheals | 1 | Atropine + Diphenoxylate to reduce addiction potential | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Anti asthmatics | 2 | Inhaled steroids, Theophylline-Diuresis, MOA through Adenosine receptor | Moderate | 0.5 |
| Pulmonary fibrosis | 1 | Drugs causing - Methysergide, Bleomycin , Nitrofurantoin | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Diuretics | 3 | Thiazides- contraindicated in gout , preferred antihypertensive with renal colic(asked twice ) , Mannitol | High | 0.75 |
| Gout | 3 | Drugs causing gout ,Peglotocase, Allopurinol | Moderate | 0.75 |
| Tolvaptan | 1 | Mechanism of action | Low | 0.25 |
| Topic Name | Times Repeated | PYQ Asked | Priority | Study Duration |
|---|---|---|---|---|
| Toclizumab | 1 | Mechanism of action | Low | 0.25 |
| Iron posoning | 1 | British AntiLewisite contraindicated | Low | 0.25 |